Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Accounts Payables: 2021-2025

Historic Accounts Payables for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $23.7 million.

  • Roivant Sciences' Accounts Payables fell 40.05% to $15.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.1 million, marking a year-over-year decrease of 40.05%. This contributed to the annual value of $23.7 million for FY2025, which is 68.87% up from last year.
  • Per Roivant Sciences' latest filing, its Accounts Payables stood at $23.7 million for FY2025, which was down 0.09% from $23.7 million recorded in FY2024.
  • Roivant Sciences' 5-year Accounts Payables high stood at $48.0 million for FY2022, and its period low was $14.0 million during FY2024.
  • Moreover, its 3-year median value for Accounts Payables was $23.7 million (2024), whereas its average is $26.9 million.
  • Per our database at Business Quant, Roivant Sciences' Accounts Payables spiked by 97.06% in 2022 and then tumbled by 62.92% in 2024.
  • Over the past 5 years, Roivant Sciences' Accounts Payables (Yearly) stood at $20.6 million in 2021, then reached $24.4 million in 2021, then soared by 68.29% to $34.6 million in 2022, then skyrocketed by 97.06% to $48.0 million in 2022, then increased by 9.39% to $37.8 million in 2023, then decreased by 26.61% to $35.2 million in 2023, then plummeted by 62.92% to $14.0 million in 2024, then slumped by 32.69% to $23.7 million in 2024, then surged by 68.87% to $23.7 million in 2025.